Skip to content

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06625684
Acronym
Key LARGO
Enrollment
200
Registered
2024-10-03
Start date
2024-12-10
Completion date
2029-12-10
Last updated
2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioblastoma

Keywords

Glioblastoma, genetic predisposition to disease, risk factors, quality of life, questionnaires, blood sample, adult brain cancer, observational study, personal medical history, survival outcomes, cancer epidemiology, genetics, medical, immunologic factors, patient outcomes, health history, occupational exposure

Brief summary

The goal of this observational study is to find out what factors affect the health and risks in adults with glioblastoma (GBM), a grade 4 brain cancer. The main questions it aims to answer are: * How do genetic and immune system factors impact survival and quality of life in GBM patients? * What occupational and medical history factors are linked to the risk of getting GBM? Participants will: * Fill out an online survey about their medical history and lifestyle. Participants will have the chance to give a blood sample (from the outer arm) for genetic and immune system testing. Blood samples will be given using a home collection kit provided by the study team.

Detailed description

This observational study aims to investigate the various factors influencing outcomes and risks in adults diagnosed with glioblastoma (GBM). Glioblastoma is a highly aggressive and malignant brain tumor, and understanding the factors that affect patient outcomes is crucial for improving management strategies and patient care. The study employs a case-only design where participants will be followed over time to observe how different factors affect their health outcomes. Participants will be selected based on their diagnosis of glioblastoma and will be included in the study regardless of current treatment status or disease stage. Findings from this study are expected to provide valuable insights into the factors affecting glioblastoma outcomes and may contribute to the development of personalized treatment strategies and risk assessment tools for better management of the disease.

Interventions

None listed

Sponsors

Duke University
Lead SponsorOTHER
Glioblastoma Research Organization
CollaboratorUNKNOWN
StacheStrong
CollaboratorUNKNOWN

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years old * Pathologically-confirmed diagnosis of glioblastoma multiforme (GBM) or grade 4 brain tumor * Participant is accessible for follow-up (has a working email address) * Participant is willing and able to comply with the study requirements

Exclusion criteria

* Those who cannot read either English or Spanish * Those who cannot view an online survey

Design outcomes

Primary

MeasureTime frameDescription
Overall SurvivalFrom date of enrollment until date of death from any cause as submitted by caregiver, up to 60 monthsOverall survival will be estimated using patient-reported date of diagnosis and assessed in three month intervals until patients are reported as deceased or are lost to follow-up
Functional Well-being as measured by the Functional Assessment of Cancer Therapy-Brain (FACT-Br) questionnaireAt time of study enrollmentEstimated using the functional well-being subscale of the FACT-Br questionnaire. The score ranges from 0 to 28, where a higher score indicates greater functional well-being.

Countries

United States

Contacts

CONTACTQuinn Ostrom, PhD
GBMsurvey@duke.edu919 -684-5301
PRINCIPAL_INVESTIGATORQuinn Ostrom, PhD

Duke University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026